World News: 13:15 GMT Thursday 16th May 2019. [Cue Biopharma, Inc. via Globe Newswire via SPi World News]
CAMBRIDGE Mass May 16 2019 GLOBE NEWSWIRE -- CueInc NASDAQ CUE an innovative immunotherapy company developing a novel proprietary class of engineered to selectively modulate the human immune to treat cancer , autoi...
Globe Newswire: 13:15 GMT Thursday 16th May 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.